Analysts' Actions: CYH EOG EXPE NTAP OUTR

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Abercrombie & Fitch ( ANF) was initiated with a buy rating at Nomura. $43 price target. Management is taking action to combat weaker sales, Nomura said.

BioMed Realty Trust ( BMR) was downgraded to hold at TheStreet Ratings.

Community Health Systems ( CYH) was downgraded at Citigroup to neutral from buy and given a $42 price target. Third quarter will be sequentially weaker, and the HMA acquisition will add leverage and operational risk, Citigroup said.

Domino's Pizza ( DPZ) was initiated with a buy rating at Keybanc. $70 price target. Company can continue to deliver solid growth and deserves a premium valuation, Keybanc said.

EOG Resources ( EOG) was upgraded at Morgan Stanley to overweight. $200 price target. Company is growing inventory and free cash flow is at an inflection point, though the company trades at a discount to its peers, Morgan Stanley said.

Eaton ( ETN) was upgraded at Morgan Stanley to overweight from neutral. $76 price target. $5 EPS in 2014 is in play and favorable risk/reward, Morgan Stanley said.

Expedia ( EXPE) was upgraded to buy at Lazard Capital Markets. $60 price target. Recent checks show solid growth and Travelocity may exceed expectations, Lazard Capital Markets said.

Gap ( GPS) was initiated with a neutral rating at Nomura. $42 price target. Total sales volume remains below 2004 levels, Nomura said.

HollyFrontier ( HFC) was downgraded at Morgan Stanley to equal weight. Valuation call, based on a $53 price target, Morgan Stanley said.

IAC/InterActiveCorp ( IACI) downgraded at Canaccord Genuity to hold from buy. Valuation call, based on a $56 price target, Canaccord Genuity said.

Moody's ( MCO) was initiated with an outperform rating at William Blair. Legal and regulatory risks are easing, and Europe and structured finance market should drive growth, William Blair said.

NetApp ( NTAP) was upgraded at UBS to buy from neutral and given a $50 price target. The company is gaining share and the product cycle will be a benefit, UBS said.

Outerwall ( OUTR) was downgraded at Pacific Crest to underperform from sector perform. DVD rentals will likely continue to be hurt by a technology transition, Pacific Crest said. Fair value is near $32.

Rockwood ( ROC) was downgraded at Deutsche Bank to hold from buy. $70 price target. Valuation call, as the stock is up 29% year to date, Deutsche Bank said.

Salix Pharmaceuticals ( SLXP) was upgraded at Leerink Swann to outperform from market perform. $80 price target. Outlook is improving for Xifaxan, Leerink Swann said.

South Jersey Industries ( SJI) was downgraded to hold at TheStreet Ratings.

Cimarex ( XEC) was upgraded at Morgan Stanley to overweight. $105 price target. Permian basin could drive growth for the next several years, Morgan Stanley said.

STOCK COMMENTS / EPS CHANGES

Comerica ( CMA) estimates, price target were lowered at BMO Capital Markets. Estimates were also cut, given lower realized loan growth, said BMO Capital Markets. Market Perform rating.

The Cooper Companies ( COO) numbers were raised at Jefferies. Shares are now seen reaching $130. Estimates were also increased on another quarter of above-market CVI growth. Hold rating.

Ford ( F) estimates were raised at Jefferies through 2014. U.S. market remains healthy and company has production flexibility, Jefferies said. Buy rating and $20 price target.

Facebook ( FB) numbers were raised at Sterne Agee. Shares are now seen reaching $50. Estimates were also increased on conitnued success of mobile, Sterne Agee said. Buy rating.

Harley Davidson ( HOG) price target was raised at Citigroup to $72. Sales are accelerating, said Citigroup.

Las Vegas Sands ( LVS) numbers were raised at Citigroup. Earnings estimates were increased given SCL share gains, said Citigroup. Price target goes to $72.

Health Management Associates ( HMA) estimates were cut at Citigroup. Earnings estimates were reduced based on a sequentially weaker third quarter and acquisition distractions, said Citigroup. Price target is $15.

Mattress Firm ( MFRM) numbers were reduced at UBS. Earnings estimates were cut given weakness at vendors and tempering sales. Price target is reduced to $40.

>To submit a news tip, email: tips@thestreet.com.

Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.

More from Stocks

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Neel Kashkari: The Heart of Our Financial System Is More Radioactive Than Ever

Neel Kashkari: The Heart of Our Financial System Is More Radioactive Than Ever

Finding Stocks Right for You: Cramer's 'Mad Money' Recap (Friday 8/25/18)

Finding Stocks Right for You: Cramer's 'Mad Money' Recap (Friday 8/25/18)

Flashback Friday: Amazon, Chip Stocks, Memorial Day

Flashback Friday: Amazon, Chip Stocks, Memorial Day

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain